When 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) is performed to detect cardiac infection or inflammation, an adequate suppression of the physiological cardiac glucose metabolism plays a pivotal role to increase the interpretability and diagnostic reliability of 18F-FDG PET studies. Many studies report on different strategies to suppress the physiological cardiac glucose metabolism, including dietary preparations, pharmacological approaches, or a combination of both. We here present a comprehensive literature review of the proposed algorithms as well as a practical proposal to help nuclear medicine physicians in clinical practice.
Federico Caobelli hasn't uploaded this paper.
Let Federico know you want this paper to be uploaded.
